Clinical Trial Update: Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pioglitazone for improvement of myocardial function in patients undergoing coronary stent implantation; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Takeda | Conditions: Oxidative Stress, Coronary Artery Disease | Phase 2 | Status: COMPLETED